GLP3 - RETA 10mg

PeptiQ Labs presents Retatrutide, a cutting-edge experimental peptide known for its activity as a triple agonist targeting the Glucagon-Like Peptide-1 (GLP-1), Glucose-Dependent Insulinotropic Polypeptide (GIP), and Glucagon (GCGR) receptors.

This synthesized compound is lyophilized to ensure stability and precision for complex laboratory studies.

Our Retatrutide is manufactured under strict laboratory standards. Every batch is subjected to High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry analysis to guarantee a purity of ≥99%, ensuring that your research data remains uncompromised by contaminants.

Key Specifications:

• Active Substance: Retatrutide (GGG Tri-Agonist)
• Concentration: 10mg per vial
• Purity: ≥99% (HPLC verified)
• Form: Lyophilized (Freeze-dried) Powder
• Solubility: Soluble in bacteriostatic water or sterile saline

Manufacturer: PeptiQ Labs

Storage & Handling:

• Lyophilized: Store vials in a refrigerator (2°C - 8°C) or freezer (-20°C) for long-term storage.
• Reconstituted: Once mixed, the solution should be kept refrigerated and used immediately or within the validated research period.
• Precautions: Protect from direct sunlight and moisture.

IMPORTANT RESEARCH DISCLAIMER:

FOR RESEARCH PURPOSES ONLY. NOT FOR HUMAN CONSUMPTION. This product is a chemical reference standard intended strictly for laboratory research and analysis. It is not approved by the FDA or any regulatory agency for human or veterinary use, nor is it intended to treat, prevent, or diagnose any disease. Purchase and handling must be restricted to qualified researchers and licensed professionals in a controlled laboratory setting.